High-calcium vs high-phosphate intake and small artery tone in advanced experimental renal insufficiency

Nephrol Dial Transplant. 2006 Oct;21(10):2754-61. doi: 10.1093/ndt/gfl270. Epub 2006 Jul 12.

Abstract

Background: Disturbed calcium-phosphorus balance significantly contributes to uraemic changes in large arteries. We examined the influences of high-calcium and high-phosphate intake on small artery tone in experimental renal insufficiency.

Methods: Sixty-five rats were assigned to 5/6 nephrectomy (NTX) or sham operation. After 15 week disease progression, NTX rats were given high-calcium (3%), high-phosphate (1.5%) or control diet (0.3% calcium, 0.5% phosphate) for 12 weeks. Then isolated segments of small mesenteric arteries were studied using wire and pressure myographs.

Results: Subtotal nephrectomy reduced creatinine clearance by 60% and increased parathyroid hormone (PTH) and phosphate 12-fold and 2.7-fold, respectively. High-phosphate intake further elevated PTH and phosphate (33-fold and 5.5-fold, respectively), while the calcium diet suppressed them (to 3.5 and 62% vs sham, respectively). Ventricular B-type natriuretic peptide synthesis was increased, and blood pressure was 27 and 18 mmHg higher in NTX rats on control and phosphate diet, respectively, than in calcium-fed rats. Vasorelaxation to acetylcholine was impaired by approximately 50% in uraemic rats, and was further deteriorated by high-phosphate intake, whereas the calcium diet improved endothelium-mediated relaxation via nitric oxide and potassium channels. Small arteries of all NTX groups featured eutrophic inward remodelling: wall-to-lumen ratio was increased 1.3-fold without change in cross-sectional area.

Conclusion: High-phosphate intake had a detrimental influence on secondary hyperparathyroidism and vasodilatation, whereas high-calcium intake reduced blood pressure and PTH, alleviated volume overload and improved vasorelaxation in experimental renal insufficiency. Therefore, alterations in the calcium-phosphorus balance can significantly modulate small artery tone during impaired kidney function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Acetylcholine / pharmacology
  • Animals
  • Arteries / drug effects*
  • Arteries / physiopathology
  • Blood Pressure / drug effects
  • Calcium / metabolism
  • Calcium, Dietary / administration & dosage
  • Calcium, Dietary / pharmacology*
  • Creatine / metabolism
  • Dose-Response Relationship, Drug
  • Endothelium / metabolism
  • Hyperparathyroidism / chemically induced
  • Hyperparathyroidism / metabolism
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiopathology
  • Nitroprusside / pharmacology
  • Parathyroid Hormone / metabolism
  • Phosphates / metabolism
  • Phosphorus, Dietary / administration & dosage
  • Phosphorus, Dietary / pharmacology*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Renal Insufficiency / metabolism
  • Renal Insufficiency / pathology
  • Renal Insufficiency / physiopathology*
  • Time Factors
  • Vasodilation / drug effects

Substances

  • Calcium, Dietary
  • Parathyroid Hormone
  • Phosphates
  • Phosphorus, Dietary
  • Nitroprusside
  • 11,12-epoxy-5,8,14-eicosatrienoic acid
  • 8,11,14-Eicosatrienoic Acid
  • Creatine
  • Acetylcholine
  • Calcium